Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 3.09 trillion as of February 25, 2026. Its market cap has increased by 47.95% in one year.

Market Cap

3.09T

Enterprise Value

3.08T

Revenue

154.05B

Ranking

n/a

PE Ratio

1,336.36

Stock Price

61,200.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 3.09T, an increase of 11,639.53%. That is a compound annual growth rate of 16.90%.

Market Cap History

Date	Market Cap	% Change
Feb 25, 2026	3.09T	38.97%
Dec 30, 2025	2.22T	13.35%
Dec 30, 2024	1.96T	-12.72%
Dec 28, 2023	2.25T	148.89%
Dec 29, 2022	902.29B	-16.29%
Dec 30, 2021	1.08T	-43.84%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Yuhan	8.44T
Hanmi Pharm.	7.81T
Celltrion Pharm	3.28T
Daewoong Pharmaceutical	2.23T
GC Biopharma	2.02T
Chong Kun Dang Pharmaceutical	1.25T
Ildong Pharmaceutical	1.23T
Daewoong	1.17T

Market Cap Rankings